A critical overview of computational approaches employed for COVID-19 drug discovery

The FAIR Guiding Principles for scientific data management and stewardship

Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., Blomberg, N., Boiten, J.-W., da Silva Santos, L. B., Bourne, P. E., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.18 · Cited by 18,423 · see citing works

Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057 · see citing works

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897 · see citing works

U1 snRNP regulates cancer cell migration and invasion in vitro

Oh, J.-M., Venters, C. C., Di, C., Pinto, A. M., Wan, L., Younis, I., Cai, Z., Arai, C., So, B. R., Duan, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13993-7 · Cited by 7,157 · see citing works

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,967 · see citing works

The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities

Genheden, S., & Ryde, U. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1032936 · Cited by 5,636 · see citing works

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2223-y · Cited by 4,432 · see citing works

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405 · see citing works

ZINC 15 – Ligand Discovery for Everyone

Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224 · see citing works

Nextstrain: real-time tracking of pathogen evolution

Hadfield, J., Megill, C., Bell, S. M., Huddleston, J., Potter, B., Callender, C., Sagulenko, P., Bedford, T., & Neher, R. A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty407 · Cited by 3,154 · see citing works

DrugBank: a knowledgebase for drugs, drug actions and drug targets

Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., & Hassanali, M. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm958 · Cited by 2,852 · see citing works

Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.

Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300687e · Cited by 2,412 · see citing works

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.

Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104787 · Cited by 2,179 · see citing works

QSAR Modeling: Where have you been? Where are you going to?

Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164 · see citing works

SARS-CoV-2 vaccines in development

Krammer, F. (2020) · Nature · doi:10.1038/s41586-020-2798-3 · Cited by 2,098 · see citing works

Best Practices for QSAR Model Development, Validation, and Exploitation

Tropsha, A. (2010) · Molecular Informatics · doi:10.1002/minf.201000061 · Cited by 2,042 · see citing works

ANI-1: an extensible neural network potential with DFT accuracy at force field computational cost

Smith, J. S., Isayev, O., & Roitberg, A. E. (2017) · Chemical Science · doi:10.1039/c6sc05720a · Cited by 1,921 · see citing works

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,771 · see citing works

The rise of deep learning in drug discovery

Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770 · see citing works

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Li, G., & Clercq, E. D. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00016-0 · Cited by 1,739 · see citing works

Coronaviruses — drug discovery and therapeutic options

Zumla, A. I., Chan, J. F., Azhar, E. I., Hui, D. S. C., & Yuen, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,689 · see citing works

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

Dai, W., Zhang, B., Jiang, X.-M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., et al. (2020) · Science · doi:10.1126/science.abb4489 · Cited by 1,514 · see citing works

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30304-4 · Cited by 1,456 · see citing works

Perspective: Machine learning potentials for atomistic simulations

Behler, J. (2016) · The Journal of Chemical Physics · doi:10.1063/1.4966192 · Cited by 1,435 · see citing works

Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir

Yin, W., Mao, C., Luan, X., Shen, D.-D., Shen, Q., Su, H., Wang, X., Zhou, F., Zhao, W., Gao, M., et al. (2020) · Science · doi:10.1126/science.abc1560 · Cited by 1,219 · see citing works

Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity

Shin, D., Mukherjee, R., Grewe, D., Bojková, D., Baek, K., Bhattacharya, A., Schulz, L., Widera, M., Mehdipour, A. R., Tascher, G., et al. (2020) · Nature · doi:10.1038/s41586-020-2601-5 · Cited by 1,194 · see citing works

COVID-19: combining antiviral and anti-inflammatory treatments

Stebbing, J., Phelan, A., Griffin, I., Tucker, C., Oechsle, O., Smith, D., & Richardson, P. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30132-8 · Cited by 1,117 · see citing works

Analysis of drug combinations: current methodological landscape

Foucquier, J., & Guedj, M. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.149 · Cited by 1,115 · see citing works

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Sheahan, T. P., Sims, A. M., Zhou, S., Graham, R. L., Pruijssers, A. J. P., Agostini, M. L., Leist, S. R., Schäfer, A., Dinnon, K. H., Stevens, L. J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb5883 · Cited by 1,069 · see citing works

Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery

Yang, X. Y., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,045 · see citing works

Ultra-large library docking for discovering new chemotypes

Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998 · see citing works

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

Bouhaddou, M., Memon, D., Meyer, B., White, K. M., Rezelj, V. V., Marrero, M. C., Polacco, B. J., Melnyk, J. E., Ulferts, S., Kaake, R. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.034 · Cited by 998 · see citing works

The Coronavirus Nucleocapsid Is a Multifunctional Protein

McBride, R., van Zyl, M., & Fielding, B. C. (2014) · Viruses · doi:10.3390/v6082991 · Cited by 928 · see citing works

QSAR without borders

Muratov, E. N., Bajorath, J., Sheridan, R. P., Tetko, I. V., Filimonov, D., Poroikov, V., Oprea, T. I., Baskin, I. I., Varnek, A., Roitberg, A., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00098a · Cited by 913 · see citing works

Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein

Casalino, L., Gaieb, Z., Goldsmith, J. A., Hjorth, C. K., Dommer, A. C., Harbison, A. M., Fogarty, C. A., de Barros, E. P., Taylor, B. C., McLellan, J. S., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c01056 · Cited by 909 · see citing works

Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2

Thoms, M., Buschauer, R., Ameismeier, M., Koepke, L., Denk, T., Hirschenberger, M., Kratzat, H., Hayn, M., Mackens‐Kiani, T., Cheng, J., et al. (2020) · Science · doi:10.1126/science.abc8665 · Cited by 869 · see citing works

The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus

Gordon, C. J., Tchesnokov, E. P., Feng, J. Y., Porter, D., & Götte, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.013056 · Cited by 853 · see citing works

The promise and peril of chemical probes

Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1867 · Cited by 839 · see citing works

Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research

Fourches, D., Muratov, E., & Tropsha, A. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100176x · Cited by 832 · see citing works

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

Riva, L., Yuan, S., Yin, X., Martin‐Sancho, L., Matsunaga, N., Pache, L., Burgstaller-Muehlbacher, S., Jesus, P. D. D., Teriete, P., Hull, M. V., et al. (2020) · Nature · doi:10.1038/s41586-020-2577-1 · Cited by 821 · see citing works

Less is more: Sampling chemical space with active learning

Smith, J. S., Nebgen, B., Lubbers, N., Isayev, O., & Roitberg, A. E. (2018) · The Journal of Chemical Physics · doi:10.1063/1.5023802 · Cited by 811 · see citing works

Structure of replicating SARS-CoV-2 polymerase

Hillen, H. S., Kokić, G., Farnung, L., Dienemann, C., Tegunov, D., & Cramer, P. (2020) · Nature · doi:10.1038/s41586-020-2368-8 · Cited by 795 · see citing works

Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoV

Morse, J. S., Lalonde, T. J., Xu, S., & Liu, W. R. (2020) · ChemBioChem · doi:10.1002/cbic.202000047 · Cited by 782 · see citing works

Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase

Wang, Q., Wu, J., Wang, H., Gao, Y., Liu, Q., Mu, A., Ji, W., Yan, L., Zhu, Y., Zhu, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.034 · Cited by 779 · see citing works

An Overview of Severe Acute Respiratory Syndrome–Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01461 · Cited by 773 · see citing works

FRED Pose Prediction and Virtual Screening Accuracy

McGann, M. R. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci100436p · Cited by 772 · see citing works

Allostery in Disease and in Drug Discovery

Nussinov, R., & Tsai, C. (2013) · Cell · doi:10.1016/j.cell.2013.03.034 · Cited by 764 · see citing works

Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs

Jeon, S., Ko, M., Lee, J., Choi, I., Byun, S. Y., Park, S., Shum, D., & Kim, S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00819-20 · Cited by 675 · see citing works

Systematic integration of biomedical knowledge prioritizes drugs for repurposing

Himmelstein, D. S., Lizee, A., Hessler, C., Brueggeman, L., Chen, S. L., Hadley, D., Green, A., Khankhanian, P., & Baranzini, S. E. (2017) · eLife · doi:10.7554/elife.26726 · Cited by 666 · see citing works

Approaching coupled cluster accuracy with a general-purpose neural network potential through transfer learning

Smith, J. S., Nebgen, B. T., Zubatyuk, R. I., Lubbers, N., Devereux, C., Barros, K. M., Tretiak, S., Isayev, O., & Roitberg, A. E. (2019) · Nature Communications · doi:10.1038/s41467-019-10827-4 · Cited by 661 · see citing works

CORD-19: The COVID-19 Open Research DatasetPreprint

Wang, L. L., Lo, K., Chandrasekhar, Y., Reas, R., Yang, J., Burdick, D., Eide, D., Funk, K., Katsis, Y., Kinney, R., et al. (2020) · PubMed · doi:10.48550/arxiv.2004.10706 · Cited by 635 · see citing works

In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges

Turoňová, B., Sikora, M., Schürmann, C., Hagen, W. J. H., Welsch, S., Blanc, F. E. C., von Bülow, S., Gecht, M., Bagola, K., Hörner, C., et al. (2020) · Science · doi:10.1126/science.abd5223 · Cited by 630 · see citing works

Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

Kang, S., Yang, M., Hong, Z., Zhang, L., Huang, Z., Chen, X., He, S., Zhou, Z., Zhou, Z., Chen, Q., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.009 · Cited by 621 · see citing works

Genome-wide CRISPR Screens Reveal Host Factors Critical for SARS-CoV-2 Infection

Wei, J., Alfajaro, M. M., DeWeirdt, P. C., Hanna, R. E., Lu-Culligan, W. J., Cai, W. L., Strine, M. S., Zhang, S.-M., Graziano, V. R., Schmitz, C. O., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.028 · Cited by 559 · see citing works

Correction: Corrigendum: ER-localized auxin transporter PIN8 regulates auxin homoeostasis and male gametophyte development in Arabidopsis

Ding, Z., Wang, B., Moreno, I., Dupľáková, N., Simon, S., Carraro, N., Reemmer, J., Pěnčík, A., Chen, X., Tejos, R., et al. (2013) · Nature Communications · doi:10.1038/ncomms2452 · Cited by 555 · see citing works

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

Douangamath, A., Fearon, D., Gehrtz, P., Krojer, T. J., Lukacik, P., Owen, C. D., Resnick, E., Strain-Damerell, C. M., Aimon, A., Ábrányi‐Balogh, P., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18709-w · Cited by 541 · see citing works

Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds

Ton, A., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A. R. (2020) · Molecular Informatics · doi:10.1002/minf.202000028 · Cited by 518 · see citing works

Mapping the landscape of Artificial Intelligence applications against COVID-19

Aylett-Bullock, J., Luccioni, A. S., Pham, K. H., Lam, C. S. N., & Luengo-Oroz, M. A. (2020) · Journal of Artificial Intelligence Research · doi:10.1613/jair.1.12162 · Cited by 517 · see citing works

Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

Pruijssers, A. J. P., George, A. S., Schäfer, A., Leist, S. R., Gralinski, L. E., Dinnon, K. H., Yount, B. L., Agostini, M. L., Stevens, L. J., Chappell, J. D., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107940 · Cited by 516 · see citing works

A systematic review of SARS-CoV-2 vaccine candidates

Dong, Y.-T., Dai, T., Wei, Y., Zhang, L., Zheng, M., & Zhou, F.-F. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00352-y · Cited by 501 · see citing works

The ORF3a protein of SARS-CoV-2 induces apoptosis in cells

Ren, Y., Shu, T., Wu, D., Mu, J., Wang, C., Huang, M., Han, Y., Zhang, X.-Y., Zhou, W., Qiu, Y., et al. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0485-9 · Cited by 470 · see citing works

Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti–COVID-19 drug design

Rut, W., Lv, Z., Żmudziński, M., Patchett, S., Nayak, D., Snipas, S. J., Oualid, F. E., Huang, T. T., Békés, M., Drąg, M., et al. (2020) · Science Advances · doi:10.1126/sciadv.abd4596 · Cited by 469 · see citing works

How not to develop a quantitative structure–activity or structure–property relationship (QSAR/QSPR)

Dearden, J. C., Cronin, M. T. D., & Kaiser, K. L. E. (2009) · SAR and QSAR in Environmental Research · doi:10.1080/10629360902949567 · Cited by 468 · see citing works

Artificial intelligence in drug discovery: recent advances and future perspectives

Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464 · see citing works

Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery

Gentile, F., Agrawal, V., Hsing, M., Ton, A., Ban, F., Norinder, U., Gleave, M. E., & Cherkasov, A. R. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00229 · Cited by 455 · see citing works

Extending the Applicability of the ANI Deep Learning Molecular Potential to Sulfur and Halogens

Devereux, C., Smith, J. S., Huddleston, K. K., Barros, K. M., Zubatyuk, R. I., Isayev, O., & Roitberg, A. E. (2020) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.0c00121 · Cited by 446 · see citing works

A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics

Si, L., Bai, H., Rodas, M., Cao, W., Oh, C. Y., Jiang, A., Moller, R., Hoagland, D., Oishi, K., Horiuchi, S., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00718-9 · Cited by 440 · see citing works

Application of Generative Autoencoder in <i>De Novo</i> Molecular Design

Blaschke, T., Olivecrona, M., Engkvist, O., Bajorath, J., & Chen, H. (2018) · Molecular Informatics · doi:10.1002/minf.201700123 · Cited by 411 · see citing works

RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution

Venkataraman, S., Burra, P. V. L. S., & Selvarajan, R. (2018) · Viruses · doi:10.3390/v10020076 · Cited by 405 · see citing works

In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication

Touret, F., Gilles, M., Barral, K., Nougaırède, A., van Helden, J., Decroly, É., de Lamballerie, X. N., & Coutard, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-70143-6 · Cited by 389 · see citing works

Crystal structure of Nsp15 endoribonuclease NendoU from SARS‐CoV ‐2

Kim, Y., Jedrzejczak, R. P., Maltseva, N., Wilamowski, M., Endres, M. J., Godzik, A., Michalska, K., & Joachimiak, A. (2020) · Protein Science · doi:10.1002/pro.3873 · Cited by 386 · see citing works

<i>De Novo</i> Design of Bioactive Small Molecules by Artificial Intelligence

Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373 · see citing works

Improving Protein-Ligand Docking Results with High-Throughput Molecular Dynamics Simulations

Guterres, H., & Im, W. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00057 · Cited by 361 · see citing works

Docking and scoring with ICM: the benchmarking results and strategies for improvement

Neves, M., Totrov, M., & Abagyan, R. (2012) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-012-9547-0 · Cited by 357 · see citing works

SARS-CoV-2 Orf9b suppresses type I interferon responses by targeting TOM70

Jiang, H.-W., Zhang, H.-N., Meng, Q.-F., Xie, J., Li, Y., Chen, H., Zheng, Y.-X., Wang, X.-N., Qi, H., Zhang, J., et al. (2020) · Cellular &amp; Molecular Immunology · doi:10.1038/s41423-020-0514-8 · Cited by 351 · see citing works

Crystal structure of SARS-CoV-2 papain-like protease

Gao, X., Qin, B., Chen, P., Zhu, K., Hou, P., Wojdyla, J. A., Wang, M., & Cui, S. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.08.014 · Cited by 336 · see citing works

Delicate structural coordination of the Severe Acute Respiratory Syndrome coronavirus Nsp13 upon ATP hydrolysis

Jia, Z., Yan, L., Ren, Z.-L., Wu, L., Wang, J., Guo, J., Zheng, L., Ming, Z., Zhang, L., Lou, Z., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz409 · Cited by 334 · see citing works

Arguments in favour of remdesivir for treating SARS-CoV-2 infections

Ko, W., Rolain, J., Lee, N., Chen, P., Huang, C.-T., Lee, P., & Hsueh, P. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105933 · Cited by 317 · see citing works

Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation

Fourches, D., Muratov, E., & Tropsha, A. (2016) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00129 · Cited by 294 · see citing works

Accurate and transferable multitask prediction of chemical properties with an atoms-in-molecules neural network

Zubatyuk, R. I., Smith, J. S., Leszczyński, J., & Isayev, O. (2019) · Science Advances · doi:10.1126/sciadv.aav6490 · Cited by 278 · see citing works

SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity

Muramatsu, T., Takemoto, C., Kim, Y.-T., Wang, H., Nishii, W., Terada, T., Shirouzu, M., & Yokoyama, S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601327113 · Cited by 275 · see citing works

Enhanced succinic acid production by Mannheimia employing optimal malate dehydrogenase

Ahn, J. H., Seo, H., Park, W., Seok, J., Lee, J. A., Kim, W. J., Kim, G. B., Kim, K., & Lee, S. Y. (2020) · Nature Communications · doi:10.1038/s41467-020-15839-z · Cited by 275 · see citing works

Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein

(2020) · doi:10.1073/pnas.2021785118 · Cited by 274 · see citing works

Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin

Krafčíková, P., Šilhán, J., Nencka, R., & Bouřa, E. (2020) · Nature Communications · doi:10.1038/s41467-020-17495-9 · Cited by 272 · see citing works

GEOM, energy-annotated molecular conformations for property prediction and molecular generation

Axelrod, S., & Gómez‐Bombarelli, R. (2022) · Scientific Data · doi:10.1038/s41597-022-01288-4 · Cited by 269 · see citing works

Open science is a research accelerator

Woelfle, M., Olliaro, P., & Todd, M. H. (2011) · Nature Chemistry · doi:10.1038/nchem.1149 · Cited by 263 · see citing works

Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning

Zeng, X., Song, X. H., Ma, T., Pan, X., Zhou, Y., Hou, Y., Zhang, Z., Li, K., Karypis, G., & Cheng, F. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00316 · Cited by 258 · see citing works

X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases

Báez-Santos, Y. M., Barraza, S. J., Wilson, M. W., Agius, M. P., Mielech, A. M., Davis, N. M., Baker, S. C., Larsen, S. D., & Mesecar, A. D. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401712t · Cited by 256 · see citing works

The role of quantum mechanics in structure-based drug design

Raha, K., Peters, M. B., Wang, B., Yu, N., Wollacott, A. M., Westerhoff, L. M., & Merz, K. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.006 · Cited by 253 · see citing works

Potent Noncovalent Inhibitors of the Main Protease of SARS-CoV‑2 from Molecular Sculpting of the Drug Perampanel Guided by Free Energy Perturbation Calculations

Zhang, C., Stone, E. A., Deshmukh, M. G., et al. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00039 · Cited by 245 · see citing works

Structural basis of RNA cap modification by SARS-CoV-2

Viswanathan, T., Arya, S., Chan, S., Qi, S., Dai, N., Misra, A., Park, J., Oladunni, F. S., Kovalskyy, D., Hromas, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17496-8 · Cited by 235 · see citing works

Developing a Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein Model in a Viral Membrane

Woo, H., Park, S., Choi, Y. K., Park, T., Tanveer, M., Cao, Y., Kern, N. R., Lee, J., Yeom, M. S., Croll, T. I., et al. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c04553 · Cited by 228 · see citing works

Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53

Wassman, C. D., Baronio, R., Demir, Ö., Wallentine, B. D., Chen, C.-K., Hall, L., Salehi, F., Lin, D., Chung, B. P., Hatfield, G. W., et al. (2013) · Nature Communications · doi:10.1038/ncomms2361 · Cited by 223 · see citing works

Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2

Ghahremanpour, M. M., Tirado‐Rives, J., Deshmukh, M. G., Ippolito, J. A., Zhang, C., de Vaca, I. C., Liosi, M.-E., Anderson, K. S., & Jorgensen, W. L. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00521 · Cited by 220 · see citing works

Cryptic binding sites on proteins: definition, detection, and druggability

Vajda, S., Beglov, D., Wakefield, A., Egbert, M. E., & Whitty, A. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.05.003 · Cited by 209 · see citing works

In Silico Discovery of Candidate Drugs against Covid-19

Cava, C., Bertoli, G. R., & Castiglioni, I. (2020) · Viruses · doi:10.3390/v12040404 · Cited by 207 · see citing works

Supercomputer-Based Ensemble Docking Drug Discovery Pipeline with Application to Covid-19

Acharya, A., Agarwal, R., Baker, M. B., Baudry, J. Y., Bhowmik, D., Boehm, S., Byler, K., Chen, S., Coates, L., Cooper, C. J., et al. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01010 · Cited by 204 · see citing works

Curation of chemogenomics data

Fourches, D., Muratov, E. N., & Tropsha, A. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1881 · Cited by 193 · see citing works

Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein

Fan, X., Cao, D., Kong, L., & Zhang, X. (2020) · Nature Communications · doi:10.1038/s41467-020-17371-6 · Cited by 193 · see citing works

Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9

Littler, D. R., Gully, B. S., Colson, R. N., & Rossjohn, J. (2020) · iScience · doi:10.1016/j.isci.2020.101258 · Cited by 191 · see citing works

DrugCentral 2021 supports drug discovery and repositioning

Avram, S., Bologa, C. G., Holmes, J., Bocci, G., Wilson, T. B., Nguyen, D.-T., Curpan, R., Halip, L., Bora, A., Yang, J. J., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa997 · Cited by 189 · see citing works

SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts

Shu, T., Huang, M., Wu, D., et al. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00242-1 · Cited by 188 · see citing works

A Discussion of Measures of Enrichment in Virtual Screening: Comparing the Information Content of Descriptors with Increasing Levels of Sophistication

Bender, A., & Glen, R. C. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci0500177 · Cited by 179 · see citing works

How swamped preprint servers are blocking bad coronavirus research

Kwon, D. (2020) · Nature · doi:10.1038/d41586-020-01394-6 · Cited by 174 · see citing works

Automated De Novo Drug Design: Are We Nearly There Yet?

Schneider, G., & Clark, D. E. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201814681 · Cited by 168 · see citing works

Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition

Gimeno, A., Mestres‐Truyol, J., Ojeda, M. J., Macip, G., Saldivar‐Espinoza, B., Cereto‐Massagué, A., Pujadas, G., & Garcı́a-Vallvé, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113793 · Cited by 166 · see citing works

TCRD and pharos 2021: mining the human proteome for disease biology

Sheils, T. K., Mathias, S. L., Kelleher, K. J., Siramshetty, V. B., Nguyen, D.-T., Bologa, C. G., Jensen, L. J., Vidović, D., Koleti, A., Schürer, S. C., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa993 · Cited by 160 · see citing works

Discovery of a Novel Inhibitor of Coronavirus 3CL Protease for the Potential Treatment of COVID-19

Boras, B., Jones, R. M., Anson, B. J., Arenson, D., Aschenbrenner, L., Bakowski, M. A., Beutler, N., Binder, J., Chen, E., Eng, H., et al. (2020) · doi:10.1101/2020.09.12.293498 · Cited by 154 · see citing works

De Novo Molecular Design by Combining Deep Autoencoder Recurrent Neural Networks with Generative Topographic Mapping

Sattarov, B., Baskin, I. I., Horvath, D., Marcou, G., Bjerrum, E. J., & Varnek, A. A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00751 · Cited by 148 · see citing works

Mutation of Glu-166 Blocks the Substrate-Induced Dimerization of SARS Coronavirus Main Protease

Cheng, S., Chang, G., & Chou, C. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.4272 · Cited by 147 · see citing works

Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atom Simulations

Spinello, A., Saltalamacchia, A., & Magistrato, A. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c01148 · Cited by 147 · see citing works

Unraveling the SARS-CoV-2 Main Protease Mechanism Using Multiscale Methods

Ramos‐Guzmán, C. A., Ruiz‐Pernía, J. J., & Tuñón, I. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c03420 · Cited by 147 · see citing works

Design, synthesis, computational and biological evaluation of new anxiolytics

Geronikaki, A. A., Babaev, E. V., Dearden, J. C., et al. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.016 · Cited by 133 · see citing works

A structure-informed atlas of human-virus interactions

Lasso, G., Mayer, S. V., Winkelmann, E. R., Chu, T., Elliot, O., Patino-Galindo, J. A., Park, K., Rabadan, R., Honig, B., & Shapira, S. D. (2019) · Cell · doi:10.1016/j.cell.2019.08.005 · Cited by 133 · see citing works

Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes

Michalska, K., Kim, Y., Jedrzejczak, R. P., Maltseva, N. I., Stols, L. M., Endres, M. J., & Joachimiak, A. (2020) · IUCrJ · doi:10.1107/s2052252520009653 · Cited by 133 · see citing works

Fragment Molecular Orbital Based Interaction Analyses on COVID-19 Main Protease − Inhibitor N3 Complex (PDB ID: 6LU7)

Hatada, R., Okuwaki, K., Mochizuki, Y., et al. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00283 · Cited by 130 · see citing works

Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding

Turlington, M., Chun, A. C., Tomar, S., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.112 · Cited by 123 · see citing works

canSAR: update to the cancer translational research and drug discovery knowledgebase

Coker, E. A., Mitsopoulos, C., Tym, J. E., Komianou, A., Kannas, C. C., Micco, P. D., Villasclaras-Fernández, E. D., Özer, B., Antolín, A. A., Workman, P., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1129 · Cited by 121 · see citing works

Lessons from the COVID-19 pandemic for advancing computational drug repurposing strategies

Galindez, G., Matschinske, J., Rose, T. D., Sadegh, S., Salgado-Albarrán, M., Späth, J., Baumbach, J., & Pauling, J. K. (2021) · Nature Computational Science · doi:10.1038/s43588-020-00007-6 · Cited by 121 · see citing works

Trends in COVID-19 therapeutic clinical trials

Bugin, K., & Woodcock, J. (2021) · Nature Reviews Drug Discovery · doi:10.1038/d41573-021-00037-3 · Cited by 121 · see citing works

The flexibility of ACE2 in the context of SARS-CoV-2 infection

de Barros, E. P., Casalino, L., Gaieb, Z., Dommer, A. C., Wang, Y., Fallon, L., Raguette, L. E., Belfon, K. A. A., Simmerling, C. L., & Amaro, R. E. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.10.036 · Cited by 118 · see citing works

Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design

Lin, E., Lin, C., & Lane, H. (2020) · Molecules · doi:10.3390/molecules25143250 · Cited by 112 · see citing works

Synergistic and Antagonistic Drug Combinations against SARS-CoV-2

Bobrowski, T., Chen, L., Eastman, R. T., Itkin, Z., Shinn, P., Chen, C. Z., Guo, H., Zheng, W., Michael, S., Simeonov, A. M., et al. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.12.016 · Cited by 112 · see citing works

Coronavirus 3CL pro proteinase cleavage sites: Possible relevance to SARS virus pathology

Kiemer, L., Lund, O., Brunak, S., & Blom, N. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-72 · Cited by 110 · see citing works

Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action

Ban, F., Dalal, K., Li, H., LeBlanc, E., Rennie, P. S., & Cherkasov, A. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00137 · Cited by 109 · see citing works

In silico Drug Repurposing for COVID‐19: Targeting SARS‐CoV‐2 Proteins through Docking and Consensus Ranking

Cavasotto, C. N., & Filippo, J. I. D. (2020) · Molecular Informatics · doi:10.1002/minf.202000115 · Cited by 108 · see citing works

Crowdsourcing drug discovery for pandemics

Chodera, J. D., Lee, A. A., London, N., et al. (2020) · Nature Chemistry · doi:10.1038/s41557-020-0496-2 · Cited by 106 · see citing works

How to Discover Antiviral Drugs Quickly

Parks, J. M., & Smith, J. C. (2020) · New England Journal of Medicine · doi:10.1056/nejmcibr2007042 · Cited by 101 · see citing works

Two antioxidant 2,5-disubstituted-1,3,4-oxadiazoles (CoViTris2020 and ChloViD2020): successful repurposing against COVID-19 as the first potent multitarget anti-SARS-CoV-2 drugs

Rabie, A. M. (2020) · New Journal of Chemistry · doi:10.1039/d0nj03708g · Cited by 101 · see citing works

Déjà vu: Stimulating open drug discovery for SARS-CoV-2

Ekins, S., Mottin, M., Ramos, P. R. P. S., Sousa, B. K. D. P., Neves, B. J., Foil, D. H., Zorn, K. M., Braga, R. C., Coffee, M. P., Southan, C., et al. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.03.019 · Cited by 99 · see citing works

Drug Discovery Strategies for SARS-CoV-2

Shyr, Z. A., Gorshkov, K., Chen, C. Z., & Zheng, W. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000123 · Cited by 98 · see citing works

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2

Chen, C. Z., Shinn, P., Itkin, Z., Eastman, R. T., Bostwick, R. J., Rasmussen, L. A., Huang, R., Shen, M., Hu, X., Wilson, K. M., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.592737 · Cited by 96 · see citing works

QSAR Modeling of SARS‐CoV M pro Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2

Alves, V. M., Bobrowski, T., Melo-Filho, C. C., Korn, D., Auerbach, S. S., Schmitt, C., Muratov, E. N., & Tropsha, A. (2020) · Molecular Informatics · doi:10.1002/minf.202000113 · Cited by 95 · see citing works

canSAR: update to the cancer translational research and drug discovery knowledgebase

Mitsopoulos, C., Micco, P. D., Villasclaras-Fernández, E. D., Dolciami, D., Holt, E., Mica, I. L., Coker, E. A., Tym, J. E., Campbell, J., Che, K. H., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1059 · Cited by 95 · see citing works

Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivoPreprint

Weston, S. M., Coleman, C. M., Haupt, R., Logue, J., Matthews, K. L., & Frieman, M. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.25.008482 · Cited by 93 · see citing works

Simulating protein–ligand binding with neural network potentials

Lahey, S.-L. J., & Rowley, C. N. (2020) · Chemical Science · doi:10.1039/c9sc06017k · Cited by 91 · see citing works

Real-time sharing of drug screening data on the NCATS OpenData Portal accelerates translational researchPreprint

Brimacombe, K. R., Scully, P. C., Zhao, T., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.04.135046 · Cited by 90 · see citing works

Chemical Data Visualization and Analysis with Incremental Generative Topographic Mapping: Big Data Challenge

Gaspar, H. A., Baskin, I. I., Marcou, G., Horvath, D., & Varnek, A. A. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500575y · Cited by 88 · see citing works

A potential interaction between the SARS-CoV-2 spike protein and nicotinic acetylcholine receptors

Oliveira, A. S. F., Ibarra, A. Á., Bermúdez, I., Casalino, L., Gaieb, Z., Shoemark, D. K., Gallagher, T. C., Sessions, R. B., Amaro, R. E., & Mulholland, A. J. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.01.037 · Cited by 88 · see citing works

The COVID-19 Drug and Gene Set Library

Kuleshov, M. V., Stein, D. J., Clarke, D. J. B., Kropiwnicki, E., Jagodnik, K. M., Bartal, A., Evangelista, J. E., Hom, J., Cheng, M., Bailey, A., et al. (2020) · Patterns · doi:10.1016/j.patter.2020.100090 · Cited by 85 · see citing works

Elucidation of Cryptic and Allosteric Pockets within the SARS-CoV-2 Main Protease

Sztain, T., Amaro, R. E., & McCammon, J. A. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00140 · Cited by 83 · see citing works

Targeting ACE2–RBD Interaction as a Platform for COVID-19 Therapeutics: Development and Drug-Repurposing Screen of an AlphaLISA Proximity Assay

Hanson, Q., Wilson, K. M., Shen, M., Itkin, Z., Eastman, R. T., Shinn, P., & Hall, M. D. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00161 · Cited by 81 · see citing works

Artificial intelligence, drug repurposing and peer review

Levin, J. M., Oprea, T. I., Davidovich, S., Clozel, T., Overington, J. P., Vanhaelen, Q., Cantor, C. R., Bischof, E., & Zhavoronkov, A. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0686-x · Cited by 79 · see citing works

A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection

Ellinger, B., Bojková, D., Zaliani, A., Cinatl, J. J., Claussen, C., Westhaus, S., Keminer, O., Reinshagen, J., Kuzikov, M., Wolf, M., et al. (2021) · Scientific Data · doi:10.1038/s41597-021-00848-4 · Cited by 79 · see citing works

QSAR Modeling and Prediction of Drug–Drug Interactions

Zakharov, A. V., Varlamova, E. V., Lagunin, A. A., Dmitriev, A. V., Muratov, E. N., Fourches, D., Kuz’min, V. Е., Poroikov, V., Tropsha, A., & Nicklaus, M. C. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00762 · Cited by 77 · see citing works

Structural analysis of the putative SARS-CoV-2 primase complex

Konkoľová, E., Klíma, M., Nencka, R., & Bouřa, E. (2020) · Journal of Structural Biology · doi:10.1016/j.jsb.2020.107548 · Cited by 77 · see citing works

De Novo Molecule Design by Translating from Reduced Graphs to SMILES

Pogány, P., Arad, N., Genway, S., & Pickett, S. D. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00626 · Cited by 75 · see citing works

A Community Letter Regarding Sharing Biomolecular Simulation Data for COVID-19

Amaro, R. E., & Mulholland, A. J. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00319 · Cited by 72 · see citing works

Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics

Alamri, M. A., Altharawi, A., Alabbas, A. B., et al. (2020) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2020.08.004 · Cited by 69 · see citing works

High-Throughput Docking Using Quantum Mechanical Scoring

Cavasotto, C. N., & Aucar, M. G. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00246 · Cited by 68 · see citing works

A machine learning platform to estimate anti-SARS-CoV-2 activities

Govinda, K. C., Bocci, G., Verma, S., et al. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00335-w · Cited by 68 · see citing works

ROBOKOP KG and KGB: Integrated Knowledge Graphs from Federated Sources

Bizon, C., Cox, S., Balhoff, J. P., Kebede, Y., Wang, P., Morton, K. D., Fecho, K., & Tropsha, A. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00683 · Cited by 64 · see citing works

Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket

Fallon, L., Belfon, K. A. A., Raguette, L. E., Wang, Y., Stepanenko, D., Cuomo, A. E., Guerra, J., Budhan, S., Varghese, S., Corbo, C. P., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c00556 · Cited by 64 · see citing works

Toward A Universal Biomedical Data Translator

The Biomedical Data Translator Consortium (2018) · Clinical and Translational Science · doi:10.1111/cts.12591 · Cited by 64 · see citing works

Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collectionPreprint

Ellinger, B., Bojková, D., Zaliani, A., Cinatl, J. J., Claussen, C., Westhaus, S., Reinshagen, J., Kuzikov, M., Wolf, M., Geißlinger, G., et al. (2020) · doi:10.21203/rs.3.rs-23951/v1 · Cited by 63 · see citing works

Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 InterfacePreprint

Smith, M. D., & Smith, J. C. (2020) · ChemRxiv · doi:10.26434/chemrxiv.11871402.v3 · Cited by 61 · see citing works

Intra- and intermolecular atomic-scale interactions in the receptor binding domain of SARS-CoV-2 spike protein: implication for ACE2 receptor binding

Adhikari, P., Li, N., Shin, M. D., Steinmetz, N. F., Twarock, R., Podgornik, R., & Ching, W. Y. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp03145c · Cited by 60 · see citing works

Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysis

Hazra, S., Chaudhuri, A. G., Tiwary, B. K., & Chakrabarti, N. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118096 · Cited by 59 · see citing works

Virtual and In Vitro Antiviral Screening Revive Therapeutic Drugs for COVID-19

Bocci, G., Bradfute, S. B., Ye, C., Garcia, M. J., Parvathareddy, J., Reichard, W., Surendranathan, S., Bansal, S., Bologa, C., Perkins, D. J., et al. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00131 · Cited by 59 · see citing works

Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19

Hu, X., Shrimp, J. H., Guo, H., Xu, M., Chen, C. Z., Zhu, W. J., Zakharov, A. V., Jain, S., Shinn, P., Simeonov, A. M., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00221 · Cited by 57 · see citing works

Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography

Kneller, D. W., Phillips, G., Weiss, K. L., Zhang, Q., Coates, L., & Kovalevsky, A. Y. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00058 · Cited by 56 · see citing works

Biological activity-based modeling identifies antiviral leads against SARS-CoV-2

Huang, R., Xu, M., Zhu, H., Chen, C. Z., Zhu, W. J., Lee, E. M., He, S., Zhang, L., Zhao, J., Shamim, K., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00839-1 · Cited by 54 · see citing works

ROBOKOP: an abstraction layer and user interface for knowledge graphs to support question answering

Morton, K. D., Wang, P., Bizon, C., et al. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz604 · Cited by 49 · see citing works

Chemotext: A Publicly Available Web Server for Mining Drug–Target–Disease Relationships in PubMed

Capuzzi, S. J., Thornton, T., Liu, K., et al. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00589 · Cited by 48 · see citing works

Dynamical properties of enzyme–substrate complexes disclose substrate specificity of the SARS-CoV-2 main protease as characterized by the electron density descriptors

Khrenova, M. G., Григорьевич, Ц. В., & Nemukhin, A. V. (2020) · Physical Chemistry Chemical Physics · doi:10.1039/d0cp03560b · Cited by 42 · see citing works

Open science approaches to COVID-19

Tse, E. G., Klug, D. M., & Todd, M. H. (2020) · F1000Research · doi:10.12688/f1000research.26084.1 · Cited by 39 · see citing works

Genetic Variability of the SARS-CoV-2 Pocketome

Yazdani, S., Maio, N. D., Ding, Y., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00206 · Cited by 39 · see citing works

Virtual Screening with Generative Topographic Maps: How Many Maps Are Required?

Casciuc, I., Zabolotna, Y., Horvath, D., et al. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00650 · Cited by 33 · see citing works

Learning from history: do not flatten the curve of antiviral research!

Bobrowski, T., Melo-Filho, C. C., Korn, D., Alves, V. M., Popov, K. I., Auerbach, S. S., Schmitt, C., Moorman, N. J., Muratov, E. N., & Tropsha, A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.008 · Cited by 33 · see citing works

Ligand Entropy Is Hard but Should Not Be Ignored

Winkler, D. A. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01146 · Cited by 33 · see citing works

SmartGraph: a network pharmacology investigation platform

Zahoránszky-Köhalmi, G., Sheils, T. K., & Oprea, T. I. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-0409-9 · Cited by 31 · see citing works

Consensus virtual screening of dark chemical matter and food chemicals uncover potential inhibitors of SARS-CoV-2 main protease

Santibáñez‐Morán, M. G., López‐López, E., Prieto-Martínez, F. D., et al. (2020) · RSC Advances · doi:10.1039/d0ra04922k · Cited by 31 · see citing works

Chemography: Searching for Hidden Treasures

Zabolotna, Y., Lin, A., Horvath, D., et al. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00936 · Cited by 31 · see citing works

Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata

Hamill, P., Hudson, D., Kao, R. Y. T., Chow, P., Raj, M., Xu, H., Richer, M. J., & Jean, F. (2006) · Biological Chemistry · doi:10.1515/bc.2006.131 · Cited by 28 · see citing works

Six Laws of Open Source Drug Discovery

Todd, M. H. (2019) · ChemMedChem · doi:10.1002/cmdc.201900565 · Cited by 27 · see citing works

Targeting ACE2-RBD interaction as a platform for COVID19 therapeutics: Development and drug repurposing screen of an AlphaLISA proximity assayPreprint

Hanson, Q., Wilson, K. M., Shen, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.16.154708 · Cited by 27 · see citing works

Discovery of Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 In VitroPreprint

Bobrowski, T., Chen, L., Eastman, R. T., Itkin, Z., Shinn, P., Chen, C., Guo, H., Zheng, W., Michael, S., Simeonov, A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.29.178889 · Cited by 26 · see citing works

QSAR analysis of poliovirus inhibition by dual combinations of antivirals

Muratov, E. N., Varlamova, E. V., Artemenko, A. G., Полищук, П. Г., Nikolaeva–Glomb, L., Galabov, A. S., & Kuz’min, V. Е. (2013) · Structural Chemistry · doi:10.1007/s11224-012-0195-8 · Cited by 21 · see citing works

Leveraging an Open Science Drug Discovery Model to Develop CNS-Penetrant ALK2 Inhibitors for the Treatment of Diffuse Intrinsic Pontine Glioma

Smil, D. V., Wong, J. F., Williams, E. P., Adamson, R. J., Howarth, A., McLeod, D., Mamai, A., Kim, S., Wilson, B. J., Kiyota, T., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01199 · Cited by 21 · see citing works

COVID-KOP: integrating emerging COVID-19 data with the ROBOKOP database

Korn, D., Bobrowski, T., Li, M., et al. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa718 · Cited by 20 · see citing works

Predicted structure and fold recognition for the glutamyl tRNA reductase family of proteins

Brody, S. S., Gough, S. P., & Kannangara, C. G. (1999) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(19991115)37:3 · Cited by 18 · see citing works

De novo Molecular Design with Generative Long Short-term Memory

Grisoni, F., & Schneider, G. (2019) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2019.1006 · Cited by 18 · see citing works

Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epi-thelial cells with metabolic and protein-protein interaction networks

Karakurt, H. U., & Pir, P. (2020) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-2005-115 · Cited by 16 · see citing works

A Chemographic Audit of anti‐Coronavirus Structure‐activity Information from Public Databases (ChEMBL)

Horvath, D., Orlov, A. A., Osolodkin, D. I., et al. (2020) · Molecular Informatics · doi:10.1002/minf.202000080 · Cited by 15 · see citing works

Virtual Screening and Design with Machine Intelligence Applied to Pim‐1 Kinase Inhibitors

Schneider, P., Welin, M., Svensson, B. R., Walse, B., & Schneider, G. (2020) · Molecular Informatics · doi:10.1002/minf.202000109 · Cited by 11 · see citing works

Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein InteractomePreprint

Karunakaran, K. B., Balakrishnan, N., & Ganapathiraju, M. K. (2020) · doi:10.21203/rs.3.rs-30363/v1 · Cited by 11 · see citing works

Viribus Unitis: Drug Combinations as a Treatment Against COVID-19Preprint

Muratov, E. N., & Zakharov, A. V. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12143355.v1 · Cited by 10 · see citing works

External validation of structure-biodegradation relationship (SBR) models for predicting the biodegradability of xenobiotics

Devillers, J., Pandard, P., & Richard, B. (2013) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2013.848632 · Cited by 8 · see citing works

Autophagy dark genes: Can we find them with machine learning?Preprint

Oprea, T. I., Yang, J. J., Byrd, D. R., & Deretic, V. P. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/715037 · Cited by 4 · see citing works

Funders, now is the time to invest big in COVID drugs

(2021) · Nature · doi:10.1038/d41586-021-00960-w · Cited by 4 · see citing works

COVID-19 Repurposed Therapeutics Targeting the Viral Protease and Spike-protein:ACE2 Interface using MD-based Pharmacophore and Consensus Virtual ScreeningPreprint

garabato, B., Falchi, F., & Cavalli, A. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12264503.v1 · Cited by 3 · see citing works

Update to Our Reader, Reviewer, and Author Communities—April 2020

Burrows, C. J., Wang, S., Kim, H. J., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c04253 · Cited by 3 · see citing works

Confronting Racism in Chemistry Journals

Burrows, C. J., Huang, J., Wang, S., et al. (2020) · Macromolecules · doi:10.1021/acs.macromol.0c01412 · Cited by 2 · see citing works

Artificial intelligence–enabled virtual screening of ultra-large chemical libraries with deep docking

Gentile, F., Yaacoub, J. C., Gleave, J., Fernandez, M., Ton, A.-T., Ban, F., Stern, A., & Cherkasov, A. (2022) · Nature Protocols · doi:10.1038/s41596-021-00659-2 · Cited by 397 · see citing works

Artificial Intelligence for Drug Discovery: Are We There Yet?

Hasselgren, C., & Oprea, T. I. (2024) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040323-040828 · Cited by 236 · see citing works

Computational and artificial intelligence-based methods for antibody development

Kim, J., McFee, M., Fang, Q., Abdin, O., & Kim, P. M. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.12.005 · Cited by 178 · see citing works

Treatment Repurposing using Literature-related Discovery

Kostoff, R. N. (2019) · Journal of Scientometric Research · doi:10.5530/jscires.8.2.25 · Cited by 4 · see citing works

A data-driven methodology towards evaluating the potential of drug repurposing hypotheses

Santamaría, L. P., Carro, E. U., Uzquiano, M. D., Menasalvas, E., Gallardo, Y. P., & Rodríguez‐González, A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.08.003 · Cited by 22 · see citing works

The drug repurposing landscape from 2012 to 2017: evolution, challenges, and possible solutions

Polamreddy, P., & Gattu, N. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.022 · Cited by 119 · see citing works

Drug Repurposing and Multi-Target Therapies

Kumar, A. P., Lukman, S., & Nguyen, M. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20160-x · Cited by 2 · see citing works

Faculty Opinions recommendation of Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns.

Rastelli, G., & Pinzi, L. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.740542384.793588144